| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.3 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |